Valuation: Ecomax, Inc.

Market Cap 419K 376K 347K 315K 589K 39.8M 596K 4.16M 1.65M 20.86M 1.57M 1.54M 66.16M P/E 2022
-14.8x
P/E 2023 -25x
Enterprise Value 835K 749K 692K 627K 1.17M 79.28M 1.19M 8.29M 3.29M 41.56M 3.13M 3.07M 132M EV / Sales 2022
-
EV / Sales 2023 6,589,581x
Free-Float
8.59%
Yield 2022 *
-
Yield 2023 -
1 year 0
Extreme 0.0003
0
3 years 0
Extreme 4.0E-5
0.6
5 years 0
Extreme 4.0E-5
1.95
10 years 0
Extreme 4.0E-5
5.7
Manager TitleAgeSince
Chief Executive Officer 43 30/09/2022
Director TitleAgeSince
Chairman 43 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-99.83%-.--%-.--%-99.97% 714
-0.75%-0.60%+25.79%+65.24% 32.39B
+0.25%+3.98%+19.90%+65.02% 26.8B
-1.14%+0.54%-42.81%+471.12% 22.09B
-0.89%-2.04%-42.81%-14.17% 16.8B
-1.26%-6.99%-13.42% - 16.4B
-2.06%-1.10%-38.28%+40.07% 12.58B
-1.18%-0.98%+37.20% - 12.04B
-1.94%-6.50%-13.78%+197.43% 9.87B
-1.74%-0.05%-37.82%+19.42% 8.65B
Average -10.98%-1.39%-10.60%+93.02% 15.76B
Weighted average by Cap. -0.91%-0.91%-6.43%+128.85%

Financials

2022 2023
Net sales - 0.42 0.38 0.35 0.32 0.6 40.31 0.6 4.22 1.67 21.13 1.59 1.56 67
Net income -115K -103K -94.97K -86.12K -161K -10.89M -163K -1.14M -452K -5.71M -430K -421K -18.09M -89.92K -80.7K -74.52K -67.57K -126K -8.54M -128K -893K -355K -4.48M -338K -330K -14.2M
Net Debt 191K 172K 158K 144K 268K 18.15M 272K 1.9M 754K 9.51M 717K 702K 30.17M 416K 373K 344K 312K 584K 39.48M 591K 4.13M 1.64M 20.69M 1.56M 1.53M 65.62M
Logo Ecomax, Inc.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Employees
1
  1. Stock Market
  2. Stocks
  3. EMAX Stock